1. Umanath, K, Lewis, JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis 2018; 71: 884–895.
Google Scholar | Crossref | Medline2. Zhang, L, Long, J, Jiang, W, et al. Trends in chronic kidney disease in China. N Engl J Med 2016; 375: 905–906.
Google Scholar | Crossref | Medline3. Anders, HJ, Huber, TB, Isermann, B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol 2018; 14: 361–377.
Google Scholar | Crossref | Medline4. Iwai, T, Miyazaki, M, Yamada, G, et al. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study. Clin Exp Nephrol 2018; 22: 328–336.
Google Scholar | Crossref | Medline5. Li, L, Zhang, X, Li, Z, et al. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. J Diabetes Complications 2017; 31: 114–121.
Google Scholar | Crossref | Medline6. Oh, SW, Kim, S, Na, KY, et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract 2012; 97: 418–424.
Google Scholar | Crossref | Medline7. Ahlqvist, E, Storm, P, Karajamaki, A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018; 6: 361–369.
Google Scholar | Crossref | Medline8. Di Paolo, S, Fiorentino, M, De Nicola, L, et al. Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society. Nutr Metab Cardiovasc Dis 2020; 30: 2123–2132.
Google Scholar | Crossref | Medline9. American Diabetes Association . Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl. 1): S62–S69.
Google Scholar | Crossref10. Levey, AS, Stevens, LA, Schmid, CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.
Google Scholar | Crossref | Medline11. Tervaert, TW, Mooyaart, AL, Amann, K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010; 21: 556–563.
Google Scholar | Crossref | Medline12. Levey, AS, Inker, LA, Matsushita, K, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2014; 64: 821–835.
Google Scholar | Crossref | Medline13. Fiorentino, M, Bolignano, D, Tesar, V, et al. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol Dial Transplant 2017; 32: 97–110.
Google Scholar | Medline14. Liu, S, Guo, Q, Han, H, et al. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases. Int Urol Nephrol 2016; 48: 1691–1698.
Google Scholar | Crossref | Medline15. Popa, O, Stefan, G, Capusa, C, et al. Non-diabetic glomerular lesions in diabetic kidney disease: clinical predictors and outcome in an Eastern European cohort. Int Urol Nephrol 2021; 53: 739–747.
Google Scholar | Crossref | Medline16. Wong, TY, Choi, PC, Szeto, CC, et al. Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies. Diabetes Care 2002; 25: 900–905.
Google Scholar | Crossref | Medline17. Chang, TI, Park, JT, Kim, JK, et al. Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Diabetes Res Clin Pract 2011; 92: 198–204.
Google Scholar | Crossref | Medline18. Zhuo, L, Zou, G, Li, W, et al. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus. Eur J Med Res 2013; 18: 4.
Google Scholar | Crossref | Medline19. New, JP, Aung, T, Baker, PG, et al. The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study. Diabet Med 2008; 25: 564–569.
Google Scholar | Crossref | Medline20. Liu, M, Chen, X, Sun, X, et al. Validation of a differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases and the establishment of a new diagnostic model. J Diabetes 2014; 6: 519–526.
Google Scholar | Crossref | Medline21. Sasso, FC, De Nicola, L, Carbonara, O, et al. Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 498–503.
Google Scholar | Crossref | Medline22. Khoshdel, A, Carney, S, Gillies, A, et al. Potential roles of erythropoietin in the management of anaemia and other complications diabetes. Diabetes Obes Metab 2010; 10: 1–9.
Google Scholar23. Mehdi, U, Toto, RD. Anemia, diabetes, and chronic kidney disease. Diabetes Care 2009; 32: 1320–1326.
Google Scholar | Crossref | Medline24. Ito, K, Yokota, S, Watanabe, M, et al. Anemia in diabetic patients reflects severe tubulointerstitial injury and aids in clinically predicting a diagnosis of diabetic nephropathy. Intern Med 2021; 60: 1349–1357.
Google Scholar | Crossref | Medline25. Singh, DK, Winocour, P, Farrington, K. Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol 2009; 5: 204–210.
Google Scholar | Crossref | Medline26. Huth, C, Beuerle, S, Zierer, A, et al. Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study. Eur J Endocrinol 2015; 173: 643–653.
Google Scholar | Crossref | Medline27. Berger, M, Mönks, D, Wanner, C, et al. Diabetic nephropathy: an inherited disease or just a diabetic complication? Kidney Blood Press Res 2003; 26: 143–154.
Google Scholar | Crossref28. Wang, Y, Zhao, L, Zhang, J, et al. Implications of a family history of diabetes and rapid eGFR decline in patients with type 2 diabetes and biopsy-proven diabetic kidney disease. Front Endocrinol 2019; 10: 855.
Google Scholar | Crossref | Medline29. UK Prospective Diabetes Study Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–853.
Google Scholar | Crossref | Medline30. The ADVANCE Collaborative Group . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–2572.
Google Scholar | Crossref | Medline31. Wright, LA, Hirsch, IB. Metrics beyond hemoglobin A1C in diabetes management: time in range, hypoglycemia, and other parameters. Diabetes Technol Ther 2017; 19(Suppl. 2): S16–S26.
Google Scholar | Crossref | Medline